MIAMI, Feb. 27, 2019 -- InvestorsHub
NewsWire -- Progressive Care
Inc. (OTCQB: RXMD), a
personalized healthcare services and technology company, today
announced that its wholly owned subsidiary PharmCo,
LLC has met all three of the performance measures and
is in the top 10% in the nation evaluated by Humana Inc., a
leading health and well-being company, as part of its Rx Quality
Network program. As a result of PharmCo’s performance scores for
2018, the company will receive the maximum payout offered by Humana
as part of the program’s rewards.
Provided by Humana Pharmacy
Solutions, a division of Humana Inc., the Rx Quality
Network focuses on the health outcomes of patient care related to
medication adherence, in addition to rewarding pharmacies for
adherence performance. The program aims to partner with
participating pharmacies to improve member adherence in targeted
drug classes, which may result in higher-quality care. The
quality-based network rewards pharmacies on performance and
establishes their pharmacy in-network/preferred for PDP/MAPD
plans.
“We are very proud that we once again have hit all
of our performance metrics for 2018, especially that PharmCo
Pharmacy is in the top 10% in the nation. These scores are a
testament to the quality of care we offer patients,” said S. Parikh
Mars, Chief Executive Officer of Progressive Care Inc. “It is our
hope that, as a result of consistently strong adherence results,
physicians contracted with Humana will continue to lean on PharmCo
as a trusted, high-quality provider. We believe that our success
with initiatives like this one will lead to more opportunities for
growth and allow us to provide even more patients with Progressive
Care’s adherence packaging, proactive engagement model and
pharmacological expertise.”
PharmCo Pharmacy received the following performance
scores for the months of January 2018 – December
2018: http://www.globenewswire.com/NewsRoom/AttachmentNg/b13c8bac-3559-4fc2-83c3-410e6dabfd7e
The first measurement period is January through
June of each calendar year and the second period is January through
December of each calendar year. Performance used for these
measurement periods will be displayed in EQuIPP in August and
February, respectively, due to the data refresh cycles. Humana will
pay each participating pharmacy 50 percent of the performance
payment calculated with respect to the January through June
measurement period after the calculation for that measurement
period. This payment amount will be deducted from the performance
payment calculated for the second measurement period of January
through December (full year calculation), which will be paid after
the calculation for that measurement period.
The following targeted drug classes are directly
tied to the Centers for Medicare & Medicaid Services Part D
Stars adherence measures:
- Diabetes Medications: Non-insulin diabetes medications
(including biguanides, sulfonylureas, DPP-IV inhibitors, TZDs,
incretin mimetics, meglitinides and SGLT2 inhibitors)
- Hypertension Medications: Renin angiotensin system (RAS)
antagonists (including ACE inhibitors, ARBs and direct renin
inhibitors)
- Cholesterol Medications: Statins
Progressive Care continues to make advances in
becoming a leader in personalized healthcare and tele-pharmacy
services through its many efforts to expand and educate its
network. In 2018, Progressive Care earned its LegitScript
certification verifying PharmCo Pharmacy to be a safe
and credible online health resource. The company also launched
DischargeRx, a program designed to improve engagement
between hospitals and patients, designed to help
hospitals like Westchester General provide the best
transitional care to its patients, while still preserving hospital
resources.
Go to Humana.com/Pharmacy to learn more about
Humana Pharmacy Solutions and its Rx Quality Network program.
For more information about Progressive Care, please
visit the company’s website.
Connect and stay in touch with us on social
media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care
Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a
South Florida health services organization and provider of
prescription pharmaceuticals, compounded medications, provider of
tele-pharmacy services, the sale of anti-retroviral medications,
medication therapy management (MTM), the supply of prescription
medications to long term care facilities, and health practice risk
management.
About Humana Pharmacy
Solutions
Humana Pharmacy Solutions, a division of Humana Inc., manages
traditional pharmacy benefits with member-focused strategies to
yield savings in pharmacy and total health expense. Providing
prescription coverage for both individuals and employer groups,
Humana Pharmacy Solutions strives to give members access to the
medicine they need while offering guidance on clinically proven,
therapeutically equivalent drugs that bring better value to the
member and the customer. For more information visit www.Humana.com/Pharmacy.
Cautionary Statement Regarding Forward
Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company’s
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words “anticipate,” “believe,” “estimate,” “upcoming,”
“plan,” “target,” “intend” and “expect” and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject to a
number of risks, uncertainties, and other factors that could cause
the Company's actual results, performance, prospects, and
opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact:
Kathleen Gonzales, CMW Media
Kathleen@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Sep 2023 to Sep 2024